Kings Research™ presents this information in its report titled, “Synthetic Biology Market, Share & Industry Analysis, By Technology (NGS Technology, PCR Technology, Genome Editing Technology, Others), By Product (Oligonucleotides, Cloning Technologies Kits, Xeno-Nucleic Acids), By End User (Biotechnology & Pharmaceuticals, Academic & Government Research Institutes, Others), and Regional Analysis, 2024-2031"

Synthetic Biology Market was valued at USD 17.12 billion in 2023 and is projected to reach USD 78.74 billion by 2031, growing at a CAGR of 21.15% from 2024 to 2031

List of Key Companies in Synthetic Biology Market

• Thermo Fisher Scientific Inc
• Synbio Technologies
• Merck KGaA
• Agilent Technologies Inc.
• GenScript
• Novozymes
• Codexis, Inc.
• Bota Biosciences Inc.
• Illumina, Inc.
• Synthego

Browse Full Report Details Followed by TOC @ https://www.kingsresearch.com/synthetic-biology-market-741

One of the primary drivers of the synthetic biology market is the rising demand for bio-based products and solutions. Synthetic biology enables the development of genetically engineered microorganisms that can produce biofuels, biodegradable plastics, and other environmentally friendly products. This aligns with global efforts to reduce carbon footprints and dependence on fossil fuels, fostering market growth.